Related Experiment Video
Updated: Jun 19, 2026

Generating Genetically Modified Plasmodium berghei Sporozoites
Published on: May 5, 2023
Genetically engineered, attenuated whole-cell vaccine approaches for malaria
Ashley M Vaughan1, Ruobing Wang, Stefan H I Kappe
1Seattle Biomedical Research Institute, Seattle, WA, USA.
Developing a live-attenuated sporozoite malaria vaccine offers a promising path toward sterile protection against Plasmodium falciparum. Genetically engineered parasite strains show potential for accelerated safety and efficacy testing.
Area of Science:
- Immunology
- Infectious Diseases
- Vaccinology
Background:
- Malaria remains a major global health challenge, with nearly a century of vaccine development yielding limited success.
- Subunit vaccine candidates, including RTS/S, have shown only partial efficacy, questioning the feasibility of single or multi-antigen approaches.
- Live-attenuated sporozoite immunizations in animal and experimental studies demonstrate long-lasting, sterile protection, establishing a benchmark for malaria vaccine development.
Purpose of the Study:
- To explore the potential of live-attenuated sporozoite vaccines for Plasmodium falciparum malaria.
- To investigate genetically engineered parasite strains for enhanced safety and efficacy in malaria vaccine development.
Main Methods:
- Review of historical and experimental studies on live-attenuated malaria parasite immunizations.
- Analysis of genetically engineered Plasmodium falciparum strains exhibiting full attenuation and conferring sterile protection in animal models.
Main Results:
- Live-attenuated sporozoite immunization confers long-lasting, sterile protection against malaria infection in preclinical models.
- Genetically engineered parasite strains are fully attenuated during liver-stage infection and provide complete sterile protection in animal models.
Conclusions:
- Genetically engineered live-attenuated sporozoite vaccines represent a viable and promising strategy for developing a highly efficacious malaria vaccine.
- Accelerated safety and efficacy testing in human challenge models and malaria-endemic areas is supported for these advanced vaccine candidates.
More Related Videos
08:46Myeloid Cell Isolation from Mouse Skin and Draining Lymph Node Following Intradermal Immunization with Live Attenuated Plasmodium Sporozoites
Published on: May 18, 2016
09:13Understanding the Development of Compensatory Pathways in a Mutant Malaria Parasite Harbouring Hypomorphic Allele of Plant-Like Kinases
Published on: November 22, 2024
Related Concept Videos
Malaria
Vaccines
Microorganisms in Medicine and Therapeutics
Vaccine Production